Our previous findings also showed a substantial upregulation of IGFBP3 in both α-SMA-expressing stromal cells and tumor cells; unfortunately, expression levels of IGF2 could not be evaluated in that study as it was not included within the analysis panel [36]. This evidence concerns the gene IGF2 and neoplasm.